Mapping the human skeletal muscle proteome: progress and potential. (2nd September 2017)

• Record Type: Journal Article
• Authors: Capitanio, Daniele; Moriggi, Manuela; Gelfi, Cecilia
• Is Part Of: Expert review of proteomics. Volume 14:Number 9(2017)
• Page Start: 825
• Page End: 839
• Publication Date: 2017-09-02
• Subjects: Skeletal muscle -- sarcopenia -- exercise -- hypoxia -- muscular dystrophies -- 2-D DIGE -- iTRAQ labelling -- mass spectrometry -- LC-MS/MS; Proteins -- Biotechnology -- Periodicals; Proteomics -- Periodicals; 572.6
• DOI: 10.1080/14789450.2017.1364996
• Languages: English
• ISSNs: 1478-9450

Abstract

ABSTRACT: Introduction : Human skeletal muscle represents 40% of our body mass and deciphering its proteome composition to further understand mechanisms regulating muscle function under physiological and pathological conditions has proved a challenge. The inter-individual variability, the presence of structurally and functionally different muscle types and the high protein dynamic range require carefully selected methodologies for the assessment of the muscle proteome. Furthermore, physiological studies are understandingly hampered by ethical issues related to biopsies on healthy subjects, making it difficult to recruit matched controls essential for comparative studies. Areas covered : This review critically analyses studies performed on muscle to date and identifies what still remains unknown or poorly investigated in physiological and pathological states, such as training, aging, metabolic disorders and muscular dystrophies. Expert commentary : Efforts should be made on biological fluid analyses targeting low abundant/low molecular weight fragments generated from muscle cell disruption to improve diagnosis and clinical monitoring. From a methodological point of view, particular attention should be paid to improve the characterization of intact proteins and unknown post translational modifications to better understand the molecular mechanisms of muscle disorders.